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Abstract
31 P-nuclear magnetic resonance spectroscopy was used to investigate in vivo the energy metabolism of the calf muscle in
a 10-year-old patient with adenylosuccinate lyase deficiency and severe psychomotor retardation. The patient showed a
markedly reduced PCrrP molar ratio, known to well represent the cytosolic phosphorylation potential, due to low PCr andi
high P content in resting muscle. Moreover, intracellular ATP concentration was significantly lower than in the controli
group both at rest and at the end of post-exercise recovery. The rate of patient’s PCr recovery after an exercise in ischaemic
conditions was also out of the reference range, suggesting a reduced ability of mitochondria to respond to metabolic needs.
q 1997 Elsevier Science B.V. All rights reserved.
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1. Introduction
Adenylosuccinase adenylosuccinate lyase; EC
.4.3.2.2 deficiency is an autosomal recessive disorder
characterised by the accumulation in the biological
fluids of succinylaminoimidazole carboxamide ribo-
Abbreviations: MRS, magnetic resonance spectrometry; PCr,
phosphocreatine; S-Ado, succinyladenosine; SAICA, succiny-
laminoimidazole carboxamide; TC, time constant.
) Corresponding author. Fax: q39 6 4440062.
 . side SAICA riboside and succinyladenosine S-
.Ado , which are formed by dephosphorylation of the
w xtwo substrates of the enzyme 1,2 . The defect has
been diagnosed hitherto in 21 subjects. Its clinical
picture is markedly heterogeneous, with as a rule
psychomotor retardation, often epilepsy and autistic
features, sometimes muscle wasting and growth fail-
ure. Adenylosuccinase catalyses two analogous reac-
tions, both involving the trans-elimination of fu-
marate: the conversion of succinylaminoimidazole
carboxamide ribotide into aminoimidazole carboxam-
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ide ribotide along the de novo purine pathway, and
the formation of AMP from adenylosuccinate in the
conversion of inosine monophosphate into adenine
w xnucleotides 3 . In addition to its role in purine
biosynthesis, adenylosuccinase also participates, to-
gether with adenylate deaminase and adenylosucci-
w xnate synthetase, in the purine nucleotide cycle 4 .
This cycle prevents AMP accumulation following
ATP catabolism, and this in turn displaces the adeny-
w xlate kinase reaction toward ATP formation 5 . More-
over, the purine nucleotide cycle plays a role in
maintaining the adenylate energy charge through the
generation of intermediates for the citric-acid cycle
w xfrom amino acids 6 and through the stimulation of
w xthe activities of glycogen phosphorylase 7 and of
w xphosphofructokinase 8 , thus enhancing the rate of
glycolysis.
The aim of this work was to ascertain by 31P-mag-
31 .netic resonance spectrometry P-MRS whether the
impairment of the purine nucleotide cycle could af-
fect the energy metabolism in patient with adenylo-
succinase deficiency.
2. Materials and methods
2.1. Patient and control subjects
The adenylosuccinase-deficient patient was de-
w xscribed previously elsewhere 2 . At the time of
study, she was aged 10 years. The cardinal symptoms
were a severe psychomotor retardation accompanied
by epilepsy. Growth including head circumference,
muscle tone and reflexes were normal; the gait was
awkward. The concentration of S-Ado and SAICA
riboside in the urine was 0.075 molrmol creatinine
and 0.06 molrmol creatinine, respectively. Adenylo-
succinase activity in erythrocytes and mixed periph-
eral blood lymphocytes was reduced to approx. 30%
of normal; measurements of enzyme activity in mus-
cle as well as in other tissues were not performed,
since parents refused permission. The relatives of the
patient were asymptomatic and did not excrete appre-
ciable amounts of succinylnucleosides. Normal con-
trol subjects, matched for age and sex and free from
any neurological or muscular disorder, volunteered
for the study. Informed consent was obtained in all
cases.
2.2. Magnetic resonance spectroscopy
The spectra were acquired by a General Electric
1.5 T Signa system with a spectroscopy accessory as
w xpreviously reported 9 . All spectroscopic measure-
ments were performed according to the quantification
and quality assessment protocols defined by the EEC
Concerted Research Project on ‘Tissue Characterisa-
w xtion by MRS and MRI’, COMAC-BME II.1.3 10 .
Briefly, radio frequency pulses at 25.866 MHz with a
pulse width of 400 ms and a transmitter power of 0.5
kW were transmitted by a surface coil 20.5 cm
.diameter; General Electrics and the resonance sig-
nals were collected by a 7.5 cm receiving coil. A data
table of 1 K complex points was collected for each
transient. The band width was 2 kHz. The delay
between transmission and reception was 0.5 ms and
the acquisition duration was 250 ms. The
stimulation-response sequence was repeated every 5
s.
All spectroscopic measurements were performed
on calf muscles by placing the surface coil directly
on the skin. After optimising the magnetic field
 .homogeneity FWMH 0.25–0.35 ppm , 60 transients
were accumulated at rest in 5 min, while during
 .recovery from exercise 2-FID data blocks 10 s were
recorded for 10 min. The accumulated spectra were
transferred to the data station and processed using a 4
Hz line broadening and manual phasing. The limits of
all the peaks were marked manually on each spec-
trum after phasing. The peak areas were calculated by
integrating the signal between the limits as previously
w xreported 11 .
2.3. Exercise
The patient was induced to perform work with her
calf muscles by forcing plantar flexions outside the
magnet in ischaemic conditions obtained by inflating
a cuff above systolic pressure around her thigh. Then,
the patient was quickly re-positioned in the magnet
and the cuff released to allow the assessment of
recovery kinetics. To re-position the patient inside the
magnet 20–30 s were enough. As soon as the patient
 .was repositioned, one 2-FID data block 10 s was
recorded to be considered ‘zero time’ of recovery and
the cuff released immediately afterwards. Patient’s
relatives and controls performed in-magnet isokinetic
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aerobic exercise by rhythmically pressing a pedal
connected with a pneumatic ergometer according to
w xthe ramp protocol exercise 9 . As soon as the last
minute of work was completed and the corresponding
 .12 FIDs recorded, one 2-FID data block 10 s was
also recorded to be considered ‘zero time’ of recov-
ery and the exercise stopped immediately afterwards.
2.4. Calculations and data analysis
Intracellular pH values were calculated from the
chemical shift differences between inorganic phos-
 .  . w xphate P and phosphocreatine PCr signals 12 .i
ATP concentration was calculated by comparison
with an external standard solution measured immedi-
ately after each exam of patient, relatives and con-
trols by using precisely the same conditions trans-
mittingrreceiving coils, system settings, field homo-
geneity, temperature, transmittingrreceiving attenua-
.tors, coil load, etc. and assuming 8.2 mM the con-
w xcentration of muscle ATP in healthy controls 13 .
w xFor calculation of ATP six healthy sex- and age-
matched subjects were used in each case. The rate of
PCr recovery, assessed with a time resolution of 10 s,
was calculated from the monoexponential equation
best-fitting the experimental points and reported as
 .time constant TC versus the minimum pH reached
w xduring recovery 9 . TC values were compared with
the reference range obtained from fifty healthy con-
trols.
3. Results
Fig. 1 reports typical spectra of patient’s calf
muscle compared with a matched healthy subject.
Fig. 1. 31P-NMR spectra of resting calf muscle from adenylosuc-
 .cinase-deficient patient A and an age-, sex- and leg size-matched
 .normal volunteer B . Each spectrum consists of 60 scans over 5
min. P s inorganic phosphate, PCrsphosphocreatine; phospho-i
monoesters peak is located to the left of the P peak; phosphodi-i
esters peak is located between P and PCr peaks. Spectra werei
scaled to reflect the corresponding muscle ATP content of patient
and control.
The 31P-MRS data from the adenylosuccinase-defi-
cient patient, her relatives, and healthy controls are
summarised in Table 1. If compared to the normal
 .values reported as mean"SD , the patient showed a
markedly reduced intracellular ATP concentration
 .5.5 mM; controls: 8.2"0.36 mM as well as a very
 .low PCrrP molar ratio 2.9; controls: 7.2"1.03 ,i
due to low PCr and high P content in resting muscle.i
A relatively high intracellular pH 7.13; controls:
.7.05"0.02 was also observed in the patient during
Table 1
31P-MRS data of calf muscle at rest, during work and recovery from a patient with adenylosuccinase deficit and her relatives compared
with 6 control subjects
Subjectrrelationship Age Rest End of work End of recovery
w x  . w x  . w x  .  . w x  .ATP mM PCr mM P mM PCrrP pH PCr % of rest ATP mMi i
Patient 10 5.5 19.2 6.70 2.9 7.13 66 4.4
Father 49 8.5 31.7 4.06 7.8 7.11 57 6.6
Mother 46 8.7 31.4 3.81 8.2 7.04 41 7.8
Sister 21 8.6 27.1 4.34 6.2 7.12 36 8.1
Controls 10 8.2 27.9 3.86 7.2 7.05 35–45 8.2
"SD 0.36 1.94 0.49 1.03 0.02 0.38
w x w x w xATP , PCr and P were calculated by comparison with an external standard solution assuming 8.2 mM the average muscle ATPi
w x w xcontent 13 . PCrrP ratio represents the phosphorylation potential in steady-state conditions 14 .i
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the rest. Relatives did not show any alteration of
31P-MRS data in their calf muscle at rest.
Patient performed muscular work by her calf mus-
cle to deplete PCr in order to assess the rate of PCr
w xrecovery. At the end of exercise, PCr fell to 66% of
resting level showing a relatively mild metabolic
activation, though sufficient to assess the kinetics of
post-exercise recovery. As shown in Fig. 2, PCr
recovery was well described by a monoexponential
equation approaching the resting steady-state value in
3–5 min. Intracellular pH dropped to a minimum
value of 6.97 during recovery. Patient’s relatives
performed the required aerobic exercise and depleted
PCr to different extents, as reported in Table 1, to
allow PCr recovery to be assessed.
In view of the linear relationship linking the rate of
PCr recovery and the lowest value of cytosolic pH
 .reached during recovery termed minimum pH, pH m
w x9 , the single TC values were plotted as a function of
 .pH Fig. 2, inset . This experimental approach lev-m
els off the different variables that influence muscle
w xmetabolic activity 14 assuring reliable comparison
Fig. 2. Pattern of PCr recovery from a patient with deficit of
 .adenylosuccinase closed symbols compared with a sex- and
 .age-matched control open symbols who reached the same per-
centile depletion of PCr and the same cytosolic pH during
recovery. The asymptotic value of either subjects reflects the
different PCr content at rest. In the inset are reported the kinetics
of PCr post-exercise recovery as a function of minimum pH
reached during recovery in the calf muscle of the patient and her
 .relatives. Recovery kinetics are reported as time constant TC of
the monoexponential function best-fitting the experimental points.
Dashed lines comprise 95% confidence interval from 50 healthy
volunteers as defined by the Root Mean Square Error of the
regression line. 1spatient; 2smother; 3s father; 4ssister.
independently of exercise protocol. The rate of pa-
tient’s PCr recovery was much lower than that of
control subjects, her TC value of 38.3 s at pH ofm
6.97 being out of reference range. On the other hand,
patient’s father, mother and sister had normal rate of
 .PCr recovery Fig. 2, inset .
At the end of recovery, patient’s muscle ATP
content was lower than at rest as well as that of her
father, while mother and sister did not show any ATP
change. We are aware that precise absolute quantita-
tion of phosphates by MRS is difficult when using a
surface coil. However, when comparison is carefully
performed between matched subjects in the same
experimental conditions that also take care of coil
load, results are reliable.
4. Discussion
The present work provides data showing an im-
pairment of muscle energy metabolism in a subject
with deficit of adenylosuccinase. At rest our patient
had a markedly reduced PCrrP ratio, known toi
w xrepresent the cytosolic phosphorylation potential 15 ,
hence showing a reduced muscle energy reserve. Low
phosphorylation potential, as shown by low PCrrPi
ratio, is typical MRS feature of resting muscle found
w xin patients with mitochondrial cytopathies 16 .
To obtain more detailed information on muscle
metabolism it is convenient to exercise the muscle
inside the magnet to study the metabolic transitions
from rest to full activity, i.e. from resting state 4 to
activated state 3 of mitochondrial respiration and vice
versa from the active state 3 to the resting state 4
during recovery. However, due to the severe psy-
chomotor retardation, it was not possible to exercise
the patient properly inside the magnet. Therefore,
after data acquisition at rest she was induced to
perform ischaemic work with her calf muscle by
forcing plantar flexions outside the magnet and then
quickly repositioned inside. Ischaemia was main-
tained during repositioning to secure the maintenance
of PCr depletion in the absence of ATP synthesis, as
it is known that there is no significant change in ATP
w xand PCr concentration during ischaemia 17–19 .
In our patient, the ability of mitochondria to re-
spond to metabolic needs appears to be severely
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reduced as judged by the slow rate of PCr recovery.
Post-exercise recovery of PCr depends entirely on
w xmitochondrial respiration 13 , thus it is regarded as a
sensitive index of mitochondrial functionality. It is
worth underlining that to assess in vivo mitochondria
functionality by MRS it is important to deplete PCr
to at least 70% of resting level independently of
w xexercise length, intensity and protocol 14 . It is
known that adenylosuccinate is engaged in the purine
w xnucleotide cycle 4 , which in turn generates interme-
w xdiates of citric acid cycle from amino acids 6 and
which is involved in stimulation of glycogen phos-
w x w xphorylase 7 and phosphofructokinase 8 . Therefore,
it is conceivable that the lack of adenylosuccinase is
also responsible for secondary malfunction of mito-
chondria due to defective supply of oxidizable sub-
strates either directly to the citric-acid cycle from
aminoacids or as pyruvate from the glycolytic path-
way, or both.
An outstanding result was that ATP content in
patient’s and her father’s muscles after ten min of
recovery from exercise was lower than at rest al-
though muscle metabolic activation was relatively
low in both as compared with patient’s mother and
sister and with the group of healthy volunteers who
depleted PCr to 35–45% of resting value. It is known
that submaximal work, also when performed in is-
chaemic conditions, does not result in ATP depletion
w x17–19 unless an almost complete depletion of PCr
w xis reached during exercise 20 . It is also known that
ATP depletion during work results in slow PCr re-
covery only when ATP is decreased to about 50% of
w xthe pre-exercise concentration 20 . In fact, patient’s
father showed normal rate of PCr recovery in the
presence of 22% ATP depletion.
ATP depletion at the end of recovery from a
 .relatively mild exercise shows that the pathway s
maintaining adenylate charge andror their regulation
are impaired in the skeletal muscle. This result is
consistent with the abnormal pattern of the heat
denaturation curve of erythrocyte adenylosuccinase
w x2 from the patient and from her father, the latter
showing values between a healthy subject and the
patient.
Under the reasonable assumption that the creatine
 .pool phosphocreatineqcreatine is not changed in
the patient and that both creatine kinase and myoki-
w xnase are working near equilibrium 9,13,21 , we can
hypothesise that the overall adenylate pool ATPq
.ADPqAMP is reduced after the exercise. This is
possibly due to the reduced de novo purine synthesis,
because of the enzyme defect, andror to the inability
to utilise IMP as a reservoir of purine nucleotides that
are lost through the catabolic path. The decrease in
adenylate pool can result in an impaired energy
metabolism.
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